dr. murthy on her2climb trial results in her2 breast cancer
Published 4 years ago • 720 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
17:53
dr. murthy on the clinical implications of tucatinib approval in her2 breast cancer
-
3:35
understanding the her2climb trial
-
3:21
exciting results from her2climb in her2 mbc
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
1:42
dr. hamilton on the her2climb trial in metastatic her2 breast cancer
-
0:37
copy of dr. murthy on de-escalation strategies in her2-positive breast cancer
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
1:27
dr. murthy on future of tucatinib in her2 breast cancer
-
1:52
dr. murthy on de-escalation strategies in her2-positive breast cancer
-
1:46
dr. murthy on caveats of the persephone trial in breast cancer
-
2:41
her2climb-02 trial regimen toxicities and impact
-
2:34
her2climb: sequencing in metastatic breast cancer
-
3:45
her2climb: implications for brain metastases in her2 mbc
-
6:08
the her2climb-02 trial design, results and implications
-
3:48
her2 breast cancer: future treatment landscape
-
3:15
a close look at tucatinib in her breast cancer
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
2:00
her2 metastatic breast cancer: standard of care therapies